The STAR™ Tumor Ablation Registry

TerminatedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

March 20, 2017

Study Completion Date

March 20, 2017

Conditions
Metastatic Lesions in Vertebral Bodies
Interventions
DEVICE

STAR™ Tumor Ablation System

Targeted Radiofrequency ablation of painful metastatic tumor in the vertebral body.

Trial Locations (15)

27157

Wake Forest Health Sciences, Winston-Salem

32159

Medical Imaging & Therapeutics, Lady Lake

32216

Mori Bean and Brook Radiology, Jacksonville

37920

University of Tennessee, Knoxville

55905

Mayo Clinic, Rochester

63110

Washington University, St Louis

66160

University of Kansas Medical Center, Kansas City

80045

University of Colorado, Denver

90095

University of California, Los Angeles, Los Angeles

92025

Southern California Institute of Neurological Surgery, Escondido

94520

John Muir Medical Center, Concord

95204

St. Joseph's Medical Center, Stockton

99204

Providence Sacred Heart Medical Center, Spokane

Unknown

VIR Chicago, Chicago

Medical College of Wisconsin, Milwaukee

Sponsors
All Listed Sponsors
collaborator

DFINE Inc.

INDUSTRY

lead

Merit Medical Systems, Inc.

INDUSTRY